Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Cervical Cancer
2 articles
Gut Microbiome: A New Frontier in Predicting Immunotherapy Outcomes for Gynecologic Cancers
Study reveals gut bacteria's role in immunotherapy outcomes for cervical and endometrial cancer patients.
Immunotherapy Breakthrough: Pembrolizumab Boosts Survival in Advanced Cervical Cancer
Pembrolizumab plus chemoradiotherapy significantly improves survival in high-risk cervical cancer patients.